Stryker Corporation
Stryker Corporation is a leading global medical technology company with a strong focus on orthopedic and extremity surgery, making it a pivotal force in the bunion treatment market. The company’s strategy involves continuous innovation to shift traditional surgical standards towards less invasive, patient-preferred methods. In the bunion space, Stryker’s flagship offering is the PROstep Minimally Invasive Surgery (MIS) platform. This system includes the PROstep MIS Lapidus system, launched in late 2023, which offers a minimally invasive option for 3D bunion correction with reported clinical benefits like a faster recovery, reduced scarring, and a lower recurrence rate compared to conventional open procedures. The platform also provides the PROstep MICA Screw System and MICA SOLO procedure guide, which utilize percutaneous, micro-incisions to correct bunions and a range of other forefoot and hindfoot deformities. Stryker supports its platform with best-in-class surgical training and equipment, cementing its role as a key industry leader in driving the adoption of high-efficacy, reproducible, and patient-friendly bunion surgical solutions globally.
Latest Market Research Report on Bunion Surgery Download PDF Brochure Now
Treace Medical Concepts
Treace Medical Concepts, Inc. is an innovative U.S.-based medical device company that has established itself as a pioneer in the market by focusing primarily on 3D bunion and midfoot deformity correction. Their core philosophy is to address the root cause of the bunion deformity—an unstable joint—rather than just the resulting bump, through their proprietary Tri-Plane Correction® approach. This strategy is embodied by their flagship Lapiplasty® Procedure, which uses specialized instruments and fixation to return the entire first metatarsal bone to its proper anatomical alignment. Treace also offers a comprehensive portfolio of complementary technologies, including the Micro-Lapiplasty® system, which delivers the power of Lapiplasty® through a small, cosmetic 2 cm incision, and Percuplasty™ for percutaneous 3D correction. By providing a suite of advanced, reproducible, and less-invasive solutions like Adductoplasty® and the Nanoplasty® platform, Treace aims to advance surgical standards, maximize patient satisfaction, and ensure long-term correction of complex foot deformities.
Arthrex, Inc.
Arthrex, Inc. is a leading global medical device company specializing in product development for orthopedics, with a significant and growing presence in the foot and ankle segment, including bunion surgery. The company has revolutionized the treatment of Hallux Valgus through its **Arthrex Minimally Invasive Bunionectomy** procedure. Arthrex positions its procedure as a modern alternative to traditional open surgery, achieving the critical goal of correcting the angular deformity while minimizing soft tissue trauma. This is accomplished through tiny “poke hole” incisions, where the correction is guided by advanced imaging technology. The benefits highlighted by Arthrex include less pain and swelling postsurgery, a significantly smaller average incision size (up to 76% smaller), and a faster return to weight-bearing, often resulting in an 8-week faster recovery time. By enabling surgeons to perform a custom correction specific to the patient’s deformity with high patient satisfaction, Arthrex is a vital manufacturer providing advanced tools for less invasive foot and ankle care.
Paragon 28
Paragon 28 is a pure-play medical device company dedicated to the foot and ankle orthopedic market, providing a comprehensive portfolio of products for foot and ankle surgeons. In the bunion treatment space, Paragon 28 offers the specialized **PRECISION® MIS Bunion System**, an all-in-one system designed to facilitate tri-planar bunion correction using a minimally invasive surgical (MIS) technique. The system is engineered to provide surgeons with a high degree of control and precision during the procedure. It utilizes a precision outrigger guide that aids in the critical translation and de-rotation of the metatarsal head, helping to control the distal metatarsal articulation angle (DMAA) for an accurate correction. The system includes the necessary instrumentation and cannulated screws for reliable fixation. By focusing exclusively on foot and ankle solutions and continually developing specialized systems like PRECISION® MIS, Paragon 28 has secured its position as a key company driving innovation in complex lower extremity deformity correction.
Johnson & Johnson / DePuy Synthes
Johnson & Johnson (J&J) is one of the world’s largest and most diversified healthcare companies, with its orthopedic and trauma division, DePuy Synthes, operating as a major supplier of implants and devices for all musculoskeletal segments, including foot and ankle. While historically focused on larger joint and trauma products, J&J has strategically targeted the growing elective bunion surgery market as a key opportunity for future growth. The company’s commitment in this area was underscored in August 2023 with the FDA clearance of its **TriLEAP** foot fixation device. TriLEAP is designed to be used in various trauma and elective procedures, directly including bunion surgery (hallux valgus correction). By integrating a dedicated foot fixation solution into its vast portfolio, J&J leverages its unparalleled global reach and trusted surgeon network to compete in this specialized segment, signaling its intent to become a dominant provider of fixation technology for both traditional and evolving bunion correction techniques.
Zimmer Biomet Holdings, Inc.
Zimmer Biomet Holdings, Inc. is a globally recognized leader in musculoskeletal healthcare, providing a wide array of products across orthopedics, which includes a substantial offering for the foot and ankle extremities market. As a foundational company in surgical implant technology, Zimmer Biomet is a significant provider in the bunion treatment market, offering a variety of sophisticated fixation devices and surgical systems used for hallux valgus correction. The company supports both traditional and advanced bunionectomy procedures, such as various osteotomies, with implants designed for stability and high clinical performance. Leveraging its extensive legacy in orthopedic reconstruction and trauma, Zimmer Biomet provides surgeons with the trusted, high-quality plates, screws, and instrumentation necessary for reliable bone fusion and correction of the first metatarsal deformity. The company’s comprehensive portfolio and global distribution network make it a continuous and essential resource for foot and ankle specialists worldwide.
Latest Market Research Report on Bunion Surgery Download PDF Brochure Now